Listed Company

TELIX Pharmaceuticals Ltd (ASX TLX)


Followers 304
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

Latest News on TELIX Pharmaceuticals Ltd


Covering TELIX Pharmaceuticals Ltd


Kerry Sun
Livewire Markets
Mark Gardner
MPC Markets
Harley Grosser
HD Capital Partners
Tim Johnston
Tyndall AM
Ben Richards
Seneca Financial Solutions
James Nguyen
Tyndall AM

TELIX Pharmaceuticals Ltd (ASX:TLX) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is TLX. Livewire Markets has 39 experts who have published 112 articles that have featured TELIX Pharmaceuticals Ltd. You can view all those wires here. The last time time TLX was featured was on the 03 August 2026 by Anthony Kavanagh in the wire “Return of the drug developer”. Get the latest TLX share price and other key information like TLX Financials on Market Index.

The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now